Shareholder information
Important information:
Our Company’s registered office is Mereside, Alderley Park, Alderley Edge, Cheshire, UK SK10 4TG
You can contact the Company by emailing us at info@bivictrix.com
This website will be updated so you can stay informed of Company news.
AIM Delisting
On 12 August 2024, BiVictriX Therapeutics plc (the “Company” or “BiVictriX”) announced the proposed cancellation of admission of its ordinary shares to trading on AIM, re-registration as a private limited company and adoption of new articles of association (the “Proposed Cancellation and Re-registration”).
A copy of the RNS announcement can be found here.
A copy of the circular can be found here.
On 29 August 2024, the Company announced that, at the general meeting of the Company held on 29 August 2024, all resolutions put to the Company’s shareholders with respect to the Proposed Cancellation and Re-Registration were duly passed and the admission of the Company’s ordinary shares to trading on AIM would be cancelled.
A copy of the RNS announcement can be found here.
As announced, the last day of trading in the Company’s ordinary shares on AIM was 10 September 2024 and the Company’s ordinary shares were cancelled from admission to trading on AIM effective 7:00 a.m. on 11 September 2024.
